Using mice to model Obsessive Compulsive Disorder: From genes to circuits

Neuroscience

Volumn 321, Issue , 2016, Pages 121-137

  Ahmari, Susanne E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Animal models; Anxiety; Basal ganglia; Obsessive Compulsive Disorder (OCD); Optogenetic; Orbitofrontal cortex (OFC)

Indexed keywords

DOPAMINE 1 RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER 3; RHODOPSIN;

ANIMAL BEHAVIOR; ANTERIOR CINGULATE; BASAL GANGLION; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COMPULSION; DISEASE MODEL; DSM-5; ELECTROENCEPHALOGRAM; FUNCTIONAL NEUROIMAGING; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HABITUATION; HUMAN; INHIBITION (PSYCHOLOGY); KNOCKOUT MOUSE; MOUSE MODEL; NERVE CELL NETWORK; NEUROPATHOLOGY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OPTOGENETICS; ORBITAL CORTEX; PATTERN RECOGNITION; PREPULSE INHIBITION; PRIORITY JOURNAL; REVIEW; SENSORY GATING; SLC1A1 GENE; SLITRK5 GENE; TRANSCRANIAL MAGNETIC STIMULATION; TRANSGENIC MOUSE; TRANSGENICS; ANIMAL; GENETICS; PATHOPHYSIOLOGY; PSYCHOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; HUMANS; MICE, TRANSGENIC; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84949571257     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.11.009     Document Type: Review

References (165)

1. Abbruzzese M., Bellodi L., Ferri S., Scarone S. Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study. Brain Cognit 1995, 27:202-212. 10.1006/brcg.1995.1017.
2. Abbruzzese M., Ferri S., Scarone S. The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia 1997, 35:907-912.
3. Abramovitch A., Abramowitz J.S. Improbability of response inhibition as a causal etiological factor of obsessive-compulsive disorder. Psychiatry Res 2014, 217:253-254. 10.1016/j.psychres.2014.01.050.
4. Abramovitch A., Abramowitz J.S., Mittelman A. The neuropsychology of adult obsessive-compulsive disorder: a meta-analysis. Clin Psychol Rev 2013, 33:1163-1171. 10.1016/j.cpr.2013.09.004.
5. Ahmari S.E., Risbrough V.B., Geyer M.A., Simpson H.B. Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology 2012, 37:1216-1223. 10.1038/npp.2011.308.
6. Ahmari S.E., et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 2013, 340:1234-1239. 10.1126/science.1234733.
7. Ahmari S.E., Eich T., Cebenoyan D., Smith E.E., Blair Simpson H. Assessing neurocognitive function in psychiatric disorders: a roadmap for enhancing consensus. Neurobiol Learn Mem 2014, S1074-7427(14)00125-7 [pii]10.1016/j.nlm.2014.06.011.
8. Angoa-Perez M., Kane M.J., Briggs D.I., Francescutti D.M., Kuhn D.M. Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J Visualized Exp 2013, 50978. 10.3791/50978.
9. Anticevic A., et al. Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biol Psychiatry 2014, 75:595-605. 10.1016/j.biopsych.2013.10.021S0006-3223(13)00978-5 [pii].
10. Aoyama K., et al. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 2006, 9:119-126. doi:nn1609 [pii]10.1038/nn1609.
11. Arnold P.D., Sicard T., Burroughs E., Richter M.A., Kennedy J.L. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006, 63:769-776. 63/7/769 [pii]10.1001/archpsyc.63.7.769.
12. Balleine B.W., O'Doherty J.P. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010, 35:48-69. 10.1038/npp.2009.131n pp2009131 [pii].
13. Bannon S., Gonsalvez C.J., Croft R.J., Boyce P.M. Response inhibition deficits in obsessive-compulsive disorder. Psychiatry Res 2002, 110:165-174.
14. Bari A., Robbins T.W. Inhibition and impulsivity: behavioral and neural basis of response control. Progr Neurobiol 2013, 108:44-79. 10.1016/j.pneurobio.2013.06.005.
15. Bari A., Eagle D.M., Mar A.C., Robinson E.S., Robbins T.W. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 2009, 205:273-283. 10.1007/s00213-009-1537-0.
16. Bari A., et al. Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology 2010, 35:1290-1301. 10.1038/npp.2009.233.
17. Barr L.C., Goodman W.K., Price L.H., McDougle C.J., Charney D.S. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry 1992, 53(Suppl):17-28.
18. Bassett A.S., et al. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 2003, 160:1580-1586.
19. Baxter L.R., et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988, 145:1560-1563.
20. Bernstein G.A., Victor A.M., Pipal A.J., Williams K.A. Comparison of clinical characteristics of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2010, 20:333-340. 10.1089/cap.2010.0034.
21. Beucke J.C., et al. Abnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder. JAMA Psychiatry 2013, 70:619-629. 10.1001/jamapsychiatry.2013.173.
22. Bienvenu O.J., et al. Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:710-720. 10.1002/ajmg.b.30897.
23. Bienvenu O.J., et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med 2012, 42:1-13. 10.1017/S0033291711000742.
24. Bloch M.H., Landeros-Weisenberger A., Rosario M.C., Pittenger C., Leckman J.F. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008, 165:1532-1542. 10.1176/appi.ajp.2008.08020320.
25. Boisseau C.L., et al. Behavioral and cognitive impulsivity in obsessive-compulsive disorder and eating disorders. Psychiatry Res 2012, 200:1062-1066. 10.1016/j.psychres.2012.06.010S0165-1781(12)00321-6 [pii].
26. Bouwknecht J.A., et al. Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice. Biol Psychiatry 2001, 49:557-568.
27. Bravo-Rivera C., Roman-Ortiz C., Brignoni-Perez E., Sotres-Bayon F., Quirk G.J. Neural structures mediating expression and extinction of platform-mediated avoidance. J Neurosci 2014, 34:9736-9742. 10.1523/JNEUROSCI.0191-14.2014.
28. Brown H.D., Amodeo D.A., Sweeney J.A., Ragozzino M.E. The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning. J Psychopharmacol 2012, 26:1443-1455. 10.1177/0269881111430749.
29. Brunner D., Hen R. Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann N Y Acad Sci 1997, 836:81-105.
30. Burguiere E., Monteiro P., Feng G., Graybiel A.M. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science 2013, 340:1243-1246. 10.1126/science.1232380.
31. Camarena B., Aguilar A., Loyzaga C., Nicolini H. A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol 2004, 7:49-53.
32. Campbell K.M., et al. OCD-like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. J Neurosci 1999, 19:5044-5053.
33. Castellan Baldan L., et al. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron 2014, 81:77-90. 10.1016/j.neuron.2013.10.052.
34. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., Sahakian B.J. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 2005, 29:399-419. 10.1016/j.neubiorev.2004.11.006.
35. Chamberlain S.R., Fineberg N.A., Blackwell A.D., Robbins T.W., Sahakian B.J. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry 2006, 163:1282-1284. 10.1176/appi.ajp.163.7.1282.
36. Chamberlain S.R., et al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry 2007, 164:335-338. 164/2/335 [pii]10.1176/appi.ajp.164.2.335.
37. Chamberlain S.R., et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008, 321:421-422. 10.1126/science.1154433.
38. Chen S.K., et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010, 141:775-785. 10.1016/j.cell.2010.03.055.
39. Chou-Green J.M., Holscher T.D., Dallman M.F., Akana S.F. Compulsive behavior in the 5-HT2C receptor knockout mouse. Physiol Behav 2003, 78:641-649.
40. Clark M.S., Neumaier J.F. The 5-HT1B receptor: behavioral implications. Psychopharmacol Bull 2001, 35:170-185.
41. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 2004, 304:878-880. 10.1126/science.1094987.
42. Clarke H.F., et al. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 2005, 25:532-538. 10.1523/JNEUROSCI.3690-04.2005.
43. de Wit S.J., et al. Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry 2014, 171:340-349. 10.1176/appi.ajp.2013.13040574.
44. Deacon R.M. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protocols 2006, 1:122-124. 10.1038/nprot.2006.20.
45. Di Martino A., et al. Functional connectivity of human striatum: a resting state FMRI study. Cerebral Cortex 2008, 18:2735-2747. 10.1093/cercor/bhn041.
46. Dickel D.E., et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 2006, 63:778-785. 63/7/778 [pii]10.1001/archpsyc.63.7.778.
47. Diniz J.B., et al. Outlining new frontiers for the comprehension of obsessive-compulsive disorder: a review of its relationship with fear and anxiety. Revista brasileira de psiquiatria 2012, 34(Suppl 1):S81-S91.
48. Eagle D.M., et al. Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacology 2009, 34:1311-1321. 10.1038/npp.2008.202.
49. Eagle D.M., et al. Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci 2011, 31:7349-7356. 10.1523/JNEUROSCI.6182-10.2011.
50. Eagle D.M., et al. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD. Behav Brain Res 2014, 264:207-229. 10.1016/j.bbr.2013.12.040.
51. Eaton W.W., et al. The burden of mental disorders. Epidemiol Rev 2008, 30:1-14. 10.1093/epirev/mxn011.
52. Eichstedt J.A., Arnold S.L. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?. Clin Psychol Rev 2001, 21:137-157. S0272-7358(99)00044-6 [pii].
53. Ercan-Sencicek A.G., et al. L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010, 362:1901-1908. 10.1056/NEJMoa0907006.
54. Fernandez T.V., et al. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry 2012, 71:392-402. 10.1016/j.biopsych.2011.09.034.
55. Freedman M., Oscar-Berman M. Selective delayed response deficits in Parkinson's and Alzheimer's disease. Arch Neurol 1986, 43:886-890.
56. Freedman M., Black S., Ebert P., Binns M. Orbitofrontal function, object alternation and perseveration. Cerebral Cortex 1998, 8:18-27.
57. Furr A., Lapiz-Bluhm M.D., Morilak D.A. 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats. Int J Neuropsychopharmacol 2012, 15:1295-1305. 10.1017/S1461145711001441.
58. Geller D.A. obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006, 29:353-370. 10.1016/j.psc.2006.02.012.
59. Gillan C.M., et al. Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry 2011, 168:718-726. 10.1176/appi.ajp.2011.10071062.
60. Gillan C.M., et al. Enhanced avoidance habits in obsessive-compulsive disorder. Biol Psychiatry 2014, 75:631-638. 10.1016/j.biopsych.2013.02.002.
61. Gillan C.M., et al. Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am J Psychiatry 2014, 10.1176/appi.ajp.2014.14040525.
62. Gillan C.M., et al. Counterfactual processing of economic action-outcome alternatives in obsessive-compulsive disorder: further evidence of impaired goal-directed behavior. Biol Psychiatry 2014, 75:639-646. 10.1016/j.biopsych.2013.01.018.
63. Gillan C.M., et al. Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am J Psychiatry 2015, 172:284-293. 10.1176/appi.ajp.2014.14040525.
64. Gingrich J.A., Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 2001, 155:1-10.
65. Goodman W.K., Grice D.E., Lapidus K.A., Coffey B.J. Obsessive-compulsive disorder. Psychiatr Clin North Am 2014, 37:257-267. S0193-953X(14)00058-6 [pii]10.1016/j.psc.2014.06.004.
66. Gourley S.L., Lee A.S., Howell J.L., Pittenger C., Taylor J.R. Dissociable regulation of instrumental action within mouse prefrontal cortex. Eur J Neurosci 2010, 32:1726-1734. 10.1111/j.1460-9568.2010.07438.x.
67. Greer J.M., Capecchi M.R. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002, 33:23-34.
68. Greist J.H., et al. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectrums 2003, 8:7-16.
69. Gremel C.M., Costa R.M. Orbitofrontal and striatal circuits dynamically encode the shift between goal-directed and habitual actions. Nat Commun 2013, 4:2264. 10.1038/ncomms3264.
70. Gross-Isseroff R., et al. Alternation learning in obsessive-compulsive disorder. Biol Psychiatry 1996, 39:733-738. 10.1016/0006-3223(95)00179-4.
71. Haber S.N. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003, 26:317-330.
72. Harrison B.J., et al. Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch Gen Psychiatry 2009, 66:1189-1200. 10.1001/archgenpsychiatry.2009.152.
73. Harrison B.J., et al. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry 2013, 73:321-328. 10.1016/j.biopsych.2012.10.006.
74. Hartston H.J., Swerdlow N.R. Visuospatial priming and stroop performance in patients with obsessive compulsive disorder. Neuropsychology 1999, 13:447-457.
75. Hayashi E., Kuratani K., Kinoshita M., Hara H. Pharmacologically distinctive behaviors other than burying marbles during the marble burying test in mice. Pharmacology 2010, 86:293-296. 10.1159/000321190.
76. Hoenig K., Hochrein A., Quednow B.B., Maier W., Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry 2005, 57:1153-1158. 10.1016/j.biopsych.2005.01.040.
77. Hou J.M., et al. Resting-state functional connectivity abnormalities in patients with obsessive-compulsive disorder and their healthy first-degree relatives. J Psychiatry Neurosci 2014, 39:304-311. 10.1503/jpn.130220 [pii].
78. Insel T.R. New pharmacologic approaches to obsessive compulsive disorder. J Clin Psychiatry 1990, 51(Suppl):47-51. (discussion 56-48).
79. Joel D. Current animal models of obsessive compulsive disorder: a critical review. Progr Neuropsychopharmacol Biol Psychiatry 2006, 30:374-388. 10.1016/j.pnpbp.2005.11.006.
80. Katayama K., et al. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Mol Psychiatry 2010, 15:177-184. 10.1038/mp.2008.97.
81. Koran L.M. Quality of life in obsessive-compulsive disorder. Psychiatr Clin North Am 2000, 23:509-517.
82. Leckman J.F., et al. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety 2010, 27:507-527. 10.1002/da.20669.
83. Leckman J.F., et al. obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depression Anxiety 2010, 27:507-527. 10.1002/da.20669.
84. Lewis S. Autism: grooming mice to model autism. Nat Rev Neurosci 2011, 12:248-249. 10.1038/nrn3033.
85. Maia T.V., Cooney R.E., Peterson B.S. The neural bases of obsessive-compulsive disorder in children and adults. Dev Psychopathol 2008, 20:1251-1283. 10.1017/S0954579408000606S0954579408000606 [pii].
86. Marsh R., Maia T.V., Peterson B.S. Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies. Am J Psychiatry 2009, 166:664-674. appi.ajp.2009.08091354 [pii]10.1176/appi.ajp.2009.08091354.
87. Marsh R., et al. Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder. Biol Psychiatry 2014, 75:615-622. 10.1016/j.biopsych.2013.02.004.
88. Mataix-Cols D., et al. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004, 61:564-576. 10.1001/archpsyc.61.6.56461/6/564 [pii].
89. Mataix-Cols D., Rosario-Campos M.C., Leckman J.F. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005, 162:228-238.
90. Mataix-Cols D., et al. Hoarding disorder: a new diagnosis for DSM-V?. Depress Anxiety 2010, 27:556-572. 10.1002/da.20693.
91. Mattheisen M., et al. Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS. Mol Psychiatry 2014, 10.1038/mp.2014.43mp201443 [pii].
92. Mattheisen M., et al. Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS. Mol Psychiatry 2015, 20:337-344. 10.1038/mp.2014.43.
93. McFarlane H.G., et al. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav 2008, 7:152-163. 10.1111/j.1601-183X.2007.00330.x.
94. Menzies L., et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007, 130:3223-3236. 10.1093/brain/awm205.
95. Milad M.R., Rauch S.L. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 2012, 16:43-51. S1364-6613(11)00236-1 [pii]10.1016/j.tics.2011.11.003.
96. Milad M.R., et al. A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry 2007, 62:1191-1194. S0006-3223(07)00401-5 [pii]10.1016/j.biopsych.2007.04.032.
97. Milad M.R. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. JAMA Psychiatry 2013, 70:608-618. (quiz 554). 10.1001/jamapsychiatry.2013.914.
98. Monzani B., Rijsdijk F., Harris J., Mataix-Cols D. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. JAMA psychiatry 2014, 71:182-189. 10.1001/jamapsychiatry.2013.3524.
99. Morein-Zamir S., et al. Punishment promotes response control deficits in obsessive-compulsive disorder: evidence from a motivational go/no-go task. Psychol Med 2013, 43:391-400. 10.1017/S0033291712001018.
100. Moritz S., et al. Perseveration and not strategic deficits underlie delayed alternation impairment in obsessive-compulsive disorder (OCD). Psychiatry Res 2009, 170:66-69. 10.1016/j.psychres.2008.09.003.
101. Mundt A., et al. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci 2009, 29:2401-2412. 10.1111/j.1460-9568.2009.06777.x.
102. Murphy F.C., Smith K.A., Cowen P.J., Robbins T.W., Sahakian B.J. The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology 2002, 163:42-53. 10.1007/s00213-002-1128-9.
103. Murray C.J.L., Lopez A.D. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Global burden of disease and injury series 1996, vol. I. Harvard School of Public Health.
104. Nakao T., et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry 2005, 57:901-910. 10.1016/j.biopsych.2004.12.039.
105. Olivier B., van Oorschot R. 5-HT1B receptors and aggression: a review. Eur J Pharmacol 2005, 526:207-217. 10.1016/j.ejphar.2005.09.066.
106. Page L.A., et al. A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res 2009, 174:202-209. 10.1016/j.pscychresns.2009.05.002.
107. Pauls D.L. The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med Genet 2008, 148C:133-139.
108. Pauls D.L., Abramovitch A., Rauch S.L., Geller D.A. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci 2014, 15:410-424. 10.1038/nrn3746.
109. Peca J., et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442. 10.1038/nature09965.
110. Pittenger C., Bloch M.H., Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 2011, 132:314-332. S0163-7258(11)00184-7 [pii]10.1016/j.pharmthera.2011.09.006.
111. Posner J., et al. Reduced functional connectivity within the limbic cortico-striato-thalamo-cortical loop in unmedicated adults with obsessive-compulsive disorder. Human Brain Mapping 2014, 35:2852-2860. 10.1002/hbm.22371.
112. Powell S.B., Newman H.A., Pendergast J.F., Lewis M.H. A rodent model of spontaneous stereotypy: initial characterization of developmental, environmental, and neurobiological factors. Physiol Behav 1999, 66:355-363.
113. Presti M.F., Watson C.J., Kennedy R.T., Yang M., Lewis M.H. Behavior-related alterations of striatal neurochemistry in a mouse model of stereotyped movement disorder. Pharmacol Biochem Behav 2004, 77:501-507. 10.1016/j.pbb.2003.12.004.
114. Proenca C.C., Gao K.P., Shmelkov S.V., Rafii S., Lee F.S. Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends Neurosci 2011, 34:143-153. 10.1016/j.tins.2011.01.001.
115. Pujol J., et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004, 61:720-730. 10.1001/archpsyc.61.7.720.
116. Radua J., Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry 2009, 195:393-402. 10.1192/bjp.bp.108.055046195/5/393 [pii].
117. Radua J., van den Heuvel O.A., Surguladze S., Mataix-Cols D. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 2010, 67:701-711. 10.1001/archgenpsychiatry.2010.70.
118. Rapoport J.L. Recent advances in obsessive-compulsive disorder. Neuropsychopharmacology 1991, 5:1-10.
119. Rauch S.L., Savage C.R., Alpert N.M., Fischman A.J., Jenike M.A. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 1997, 42:446-452. S0006-3223(97)00145-5 [pii]10.1016/S0006-3223(97)00145-5.
120. Rauch S.L., et al. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology 2002, 27:782-791. S0893133X02003512 [pii]10.1016/S0893-133X(02)00351-2.
121. Remijnse P.L., et al. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry 2006, 63:1225-1236. 10.1001/archpsyc.63.11.1225.
122. Remijnse P.L., et al. Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder. Psychol Med 2009, 39:1503-1518. 10.1017/S0033291708005072.
123. Rodman A.M., et al. Neuroimaging contributions to novel surgical treatments for intractable obsessive-compulsive disorder. Expert Rev Neurotherapeut 2012, 12:219-227. 10.1586/ern.11.189.
124. Rotge J.Y., et al. Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies. J Psychiatry Neurosci 2008, 33:405-412.
125. Rotge J.Y., et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry 2009, 65:75-83. 10.1016/j.biopsych.2008.06.019S0006-3223(08)00787-7 [pii].
126. Rotge J.Y., et al. Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry 2010, 67:e37-38. S0006-3223(09)01207-4 [pii]10.1016/j.biopsych.2009.10.007.
127. Roth R.M., et al. Event-related functional magnetic resonance imaging of response inhibition in obsessive-compulsive disorder. Biol Psychiatry 2007, 62:901-909. S0006-3223(06)01555-1 [pii]10.1016/j.biopsych.2006.12.007.
128. Russo M., et al. Obsessive-compulsive disorder: a "sensory-motor" problem?. Int J Psychophysiol 2014, 92:74-78. 10.1016/j.ijpsycho.2014.02.007.
129. Samuels J., et al. Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:472-477. 10.1002/ajmg.b.31184.
130. Saudou F., et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994, 265:1875-1878.
131. Saxena S. Is compulsive hoarding a genetically and neurobiologically discrete syndrome? Implications for diagnostic classification. Am J Psychiatry 2007, 164:380-384. 164/3/380 [pii]10.1176/appi.ajp.164.3.380.
132. Saxena S., Brody A.L., Schwartz J.M., Baxter L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998, 26-37.
133. Saxena S., Bota R.G., Brody A.L. Brain-behavior relationships in obsessive-compulsive disorder. Semin Clin Neuropsychiatry 2001, 6:82-101. S1084361201000107 [pii].
134. Shanahan N.A., et al. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biol Psychiatry 2009, 65:401-408. 10.1016/j.biopsych.2008.09.026S0006-3223(08)01164-5 [pii].
135. Shanahan N.A., Velez L.P., Masten V.L., Dulawa S.C. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice. Biol Psychiatry 2011, 70:1039-1048. 10.1016/j.biopsych.2011.07.032S0006-3223(11)00779-7 [pii].
136. Shmelkov S.V. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 2010, 16:598-602. (591p following 602). 10.1038/nm.2125.
137. Shugart Y.Y., et al. A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:886-892. 10.1002/ajmg.b.30914.
138. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464:763-767. 10.1038/nature08855.
139. Simon D., Adler N., Kaufmann C., Kathmann N. Amygdala hyperactivation during symptom provocation in obsessive-compulsive disorder and its modulation by distraction. Neuroimage Clin 2014, 4:549-557. 10.1016/j.nicl.2014.03.011S2213-1582(14)00041-2 [pii].
140. Smith K.S., Graybiel A.M. A dual operator view of habitual behavior reflecting cortical and striatal dynamics. Neuron 2013, 79:361-374. 10.1016/j.neuron.2013.05.038.
141. Smith K.S., Virkud A., Deisseroth K., Graybiel A.M. Reversible online control of habitual behavior by optogenetic perturbation of medial prefrontal cortex. Proc Natl Acad Sci USA 2012, 109:18932-18937. 10.1073/pnas.1216264109.
142. Snider L.A., Swedo S.E. PANDAS: current status and directions for research. Mol Psychiatry 2004, 9:900-907. 10.1038/sj.mp.4001542.
143. Stein D.J., Shoulberg N., Helton K., Hollander E. The neuroethological approach to obsessive-compulsive disorder. Compre Psychiatry 1992, 33:274-281.
144. Stein D.J., Craske M.A., Friedman M.J., Phillips K.A. Anxiety disorders, obsessive-compulsive and related disorders, trauma- and stressor-related disorders, and dissociative disorders in DSM-5. Am J Psychiatry 2014, 171:611-613. 10.1176/appi.ajp.2014.14010003.
145. Stewart S.E., et al. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:1027-1033. 10.1002/ajmg.b.30533.
146. Stewart S.E., et al. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry 2013, 18:788-798. 10.1038/mp.2012.85mp201285 [pii].
147. Stewart S.E., et al. Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet 2013, 162B:367-379. 10.1002/ajmg.b.32137.
148. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 1993, 33:298-301.
149. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001, 156:194-215.
150. Szechtman H., Sulis W., Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav Neurosci 1998, 112:1475-1485.
151. Taylor S. Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies. Mol Psychiatry 2013, 18:799-805. 10.1038/mp.2012.76.
152. Thomas A., et al. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology 2009, 204:361-373. 10.1007/s00213-009-1466-y.
153. Ting J.T., Feng G. Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol 2011, 21:842-848. S0959-4388(11)00068-7 [pii]10.1016/j.conb.2011.04.010.
154. Valerius G., Lumpp A., Kuelz A.K., Freyer T., Voderholzer U. Reversal learning as a neuropsychological indicator for the neuropathology of obsessive compulsive disorder? A behavioral study. J Neuropsychiatry Clin Neurosci 2008, 20:210-218. 10.1176/appi.neuropsych.20.2.210.
155. Van Ameringen M., Patterson B., Simpson W. DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria. Depression Anxiety 2014, 31:487-493. 10.1002/da.22259.
156. van Velzen L.S., Vriend C., de Wit S.J., van den Heuvel O.A. Response inhibition and interference control in obsessive-compulsive spectrum disorders. Front Human Neurosci 2014, 8:419. 10.3389/fnhum.2014.00419.
157. Veenstra-VanderWeele J., et al. Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder. Mol Psychiatry 2001, 6:160-167. 10.1038/sj.mp.4000806.
158. Veenstra-VanderWeele J, Xu T, Ruggiero AM, Anderson LR, Jones ST, Himle JA, Kennedy JL, Richter MA, Hanna GL, Arnold PD. Functional studies and rare variant screening of SLC1A1/EAAC1/EAAT3 in males with obsessive-compulsive disorder. Psychiatric Genetics (in press).
159. Wan Y., et al. Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. Biol Psychiatry 2014, 75:623-630. 10.1016/j.biopsych.2013.01.008.
160. Welch J.M., et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448:894-900. 10.1038/nature06104.
161. Wendland J.R., et al. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry 2009, 66:408-416. 66/4/408 [pii]10.1001/archgenpsychiatry.2009.6.
162. Williams M.T., et al. Myth of the pure obsessional type in obsessive-compulsive disorder. Depression Anxiety 2011, 28:495-500. 10.1002/da.20820.
163. Winter C., et al. High frequency stimulation and temporary inactivation of the subthalamic nucleus reduce quinpirole-induced compulsive checking behavior in rats. Exp Neurol 2008, 210:217-228. 10.1016/j.expneurol.2007.10.020.
164. Woehrle N.S., Klenotich S.J., Jamnia N., Ho E.V., Dulawa S.C. Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation. Psychopharmacology 2013, 227:545-551. 10.1007/s00213-013-2985-0.
165. Wu K., Hanna G.L., Rosenberg D.R., Arnold P.D. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav 2012, 100:726-735. S0091-3057(11)00329-7 [pii]10.1016/j.pbb.2011.10.007.